Delivery Order SPE2DB22D2206-SPE2DB24FFF58
- Not listed
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.95 firm fixed-price delivery order contract is for the supply of BUPROPION HCL XL 300 MG TABLET 500S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The federal contract award is for the delivery of BUPROPION HCL XL 150 MG TABLET 500S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,941.46 and an ultimate completion date of April 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,732.67 firm-fixed-price delivery order is for the supply of 4,562,816,824 units of Bupropion HCL XL 150 mg tablets. The award has an ultimate completion date of November 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This contract award, valued at $5,150.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUPROPION HCL XL 150 MG TABLET 500S, a generic medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The $23,494.99 firm fixed-price delivery order is for the supply of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of April 19, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560830346 bupropion HCL XL 150 mg tablets in 90-count packages. The $2,005.78 firm fixed-price delivery order has a completion date of May 5, 2023. This contract is not designated as a set-aside. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,368.94 firm fixed-price delivery order covers the supply of 4563862693 bupropion HCL XL 150 mg tablets to support military healthcare programs. The contract has a period of performance through March 6, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $28,660.47 firm fixed-price delivery order is for 4,563,336,728 BUPROPION HCL XL 300 MG TABLETS, with a completion date of January 17, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a comprehensive vehicle for...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of BUPROPION HCL XL 300 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $105,516.75 and a performance period ending on February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is a delivery order valued at $66,036.93 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567584930 ! BUPROPION HCL XL 300 MG TABLET 500S, a pharmaceutical product, with a performance period ending on March 17, 2025. The contract is a firm fixed price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFF58Delivery Order
This federal contract award, valued at $86,361.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of January 24, 2024. The contract covers the delivery of 4563416633 - BUPROPION HCL XL 150 MG TABLET 500S, a generic pharmaceutical product, to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for providing a wide range of pharmaceutical products and medical supplies to the Department of Defense. This contract award was made through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.4k | 1/23/24 |